Exercise of warrants

Energypathways

03/10/2025 12:05

RNS Number : 0390C

EnergyPathways PLC

03 October 2025

 

3 October 2025

EnergyPathways plc

 

("EnergyPathways" or the "Company")

 

Exercise of Warrants

 

EnergyPathways plc (AIM: EPP), an integrated energy transition company, announces that it has received a notice to exercise 1,750,000 warrants over new ordinary shares in the Company ("Warrant Shares"). 1,750,000 warrants were exercised at 4p per ordinary share ordinary share, amounting to gross proceeds of £70,000.

 

Admission and Total Voting Rights

 

Application will be made for the Warrant Shares to be admitted to trading on AIM, which is expected to occur on or around 9 October 2025 ("Admission"). The Warrant Shares will rank pari passu in all respects with the Company's existing Ordinary Shares currently traded on AIM.

 

Following Admission, the Company's issued share capital will comprise 199,685,414 Ordinary Shares. This number will represent the total voting rights in the Company and may be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

​

 Enquiries:

 

EnergyPathways
 Ben Clube / Max Williams
Tel: +44 (0)207 466 5000, c/o Buchanan (Financial PR)
Email : info@energypathways.uk
Cairn Financial Advisers LLP (Nominated Adviser)
Jo Turner / Louise O'Driscoll / Sandy Jamieson
Tel: +44 (0)20 7213 0880
SP Angel Corporate Finance LLP (Broker)
Richard Hail / Adam Cowl
Tel: +44 (0)20 3470 0470
Global Investment Strategy UK Limited (Joint Broker)Callum Hill / James Sheehan
Tel: +44 (0)20 7048 9000

 

For further information on EnergyPathways visit www.energypathways.uk and @energy_pathways on X (formerly Twitter).

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
IOEUPGCUUUPAGGW